ADVENTRX Pharmaceuticals (ANX)
ADVENTRX Pharmaceuticals News
2 Plunging And 1 Surging Healthcare Stocks Insiders Bought Last Week, Other Noteworthy Trades
about 14 days agoVista Partners Publishes May 2012 Newsletter
Marketwire about 19 days agoSAN FRANCISCO, CA-- - Vista Partners announced today that it published its FREE macroeconomic/small cap oriented monthly newsletter for the month of May. Each monthly newsletter from Vista contains macroeconomic ...
ADVENTRX PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
about 20 days agoADVENTRX Pharmaceuticals (ANX) Narrows Q1 Loss of 9c/Share
Street Insider about 20 days agoADVENTRX Reports First Quarter 2012 Financial Results
PR Newswire about 20 days agoSAN DIEGO, May 7, 2012 /PRNewswire/ -- ADVENTRX Pharmaceuticals, Inc. (ANX) today reported financial results for the first quarter ended March 31, 2012."In the first quarter, we focused ...
ADVENTRX Pharmaceuticals to Sponsor & Present at the Martin Center's 2012 Sickle Cell Disease Conference
PR Newswire about 41 days agoSAN DIEGO, April 16, 2012 /PRNewswire/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company is a sponsor of and will be presenting at the Martin Center's 2012 Indiana Statewide ...
Vista Partners Publishes April 2012 Newsletter
Marketwire about 48 days agoSAN FRANCISCO, CA-- - Vista Partners announced today that it published its FREE macroeconomic/small cap oriented monthly newsletter for the month of April. Each monthly newsletter from Vista contains macroeconomic ...
ADVENTRX Announces Establishment of Regulatory Advisory Board
PR Newswire about 48 days agoSAN DIEGO, April 9, 2012 /PRNewswire/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced the establishment of a Regulatory Advisory Board (RAB). The RAB will provide drug development and ...
3 Biopharma Picks: A Certain Level Of Risk Is Required
about 60 days agoVista Partners Updates Coverage on ADVENTRX Pharmaceuticals, Inc.; $3.50 Target Price
PR Newswire about 67 days agoSAN FRANCISCO, March 21, 2012 /PRNewswire/ -- Vista Partners announced today that it has updated coverage on ADVENTRX Pharmaceuticals, Inc. (AMEX: ANX - News) ("The Company" or "ANX"); and ...
ADVENTRX CEO Selected by Combined Health Agencies as a 2012 Health Hero
PR Newswire about 73 days agoSAN DIEGO, March 15, 2012 /PRNewswire/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that Brian M. Culley, its Chief Executive Officer, has been selected as a 2012 Health Hero by Combined ...
ADVENTRX PHARMACEUTICALS INC Financials
about 74 days agoFor Biotech, 'Fail' Is Making a Big Comeback
about 76 days agoAdventrx Pharmaceuticals (ANX) Files $150M Mixed Shelf
Street Insider about 80 days agoAdventrx files $150M mixed securities shelf
about 80 days agoYou may also be interested in these ANX related companies
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ANX | 0.535 | -0.01 | -0.93% | 25.53M |
| ANW | 5.27 | +0.01 | +0.19% | 243.63M |
| ANV | 27.47 | -0.20 | -0.72% | 2.463B |
| ASEI | 49.46 | +1.29 | +2.68% | 441.18M |
| ASCMA | 52.78 | +1.12 | +2.17% | 710.95M |
| ASCA | 18.42 | +0.13 | +0.71% | 605.47M |
| ASBC | 12.76 | -0.04 | -0.31% | 2.229B |
| ASA | 22.96 | +0.22 | +0.97% | |
| ARX | 6.54 | +0.01 | +0.15% | 554.72M |
| ARWRD | 4.120 | -0.05 | -1.20% |
